JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB208589

Anti-Prothrombin antibody [EPR20159]

Be the first to review this product! 리뷰 제출

|

(4 제품이 사용된 논문 )

Rabbit Recombinant Monoclonal Thrombin antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IP and reacts with Human samples. Cited in 4 publications.

대체 명칭 보기

Prothrombin, Coagulation factor II, F2

5 이미지
Flow Cytometry (Intracellular) - Anti-Prothrombin antibody [EPR20159] (AB208589)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Prothrombin antibody [EPR20159] (AB208589)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HepG2 (Human liver hepatocellular carcinoma cell line) cells labeling Prothrombin with ab208589 at 1/600 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (Alexa Fluor® 488) at 1/2000 dilution was used as the secondary antibody.

Immunocytochemistry/ Immunofluorescence - Anti-Prothrombin antibody [EPR20159] (AB208589)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Prothrombin antibody [EPR20159] (AB208589)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HepG2 (Human liver hepatocellular carcinoma cell line) cells labeling Prothrombin with ab208589 at 1/100 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HepG2 cell line.

The nuclear counter stain is DAPI (blue). Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.

Immunoprecipitation - Anti-Prothrombin antibody [EPR20159] (AB208589)
  • IP

Lab

Immunoprecipitation - Anti-Prothrombin antibody [EPR20159] (AB208589)

Prothrombin was immunoprecipitated from HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate with ab208589 at 1/50 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab208589 at 1/1000 dilution.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-Prothrombin antibody [EPR20159] (ab208589) at 1/1000 dilution

Lane 1:

HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate (Input) at 10 µg

Lane 2:

HepG2 whole cell lysate (+)

Lane 3:

Rabbit monoclonal IgG (<a href='/ko/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab208589 in HepG2 whole cell lysate (-)

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/ko/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

Observed band size: 33-72 kDa

false

Exposure time: 180s

Western blot - Anti-Prothrombin antibody [EPR20159] (AB208589)
  • WB

Supplier Data

Western blot - Anti-Prothrombin antibody [EPR20159] (AB208589)

Blocking/Dilution buffer : 5% NFDM/TBST.

Prothrombin is proteolytically cleaved into different fragments. The fragments profile is consistent with what has been described in the literature (PMID : 17637839; PMID : 21131592; PMID : 16734589).

All lanes:

Western blot - Anti-Prothrombin antibody [EPR20159] (ab208589) at 1/1000 dilution

Lane 1:

Human plasma at 20 µg

Lane 2:

Human fetal liver tissue lysate at 20 µg

Lane 3:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/ko/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/4000 dilution

Predicted band size: 70 kDa

Observed band size: 33 kDa,52 kDa,72 kDa

false

Exposure time: 3min

Western blot - Anti-Prothrombin antibody [EPR20159] (AB208589)
  • WB

Supplier Data

Western blot - Anti-Prothrombin antibody [EPR20159] (AB208589)

Blocking and diluting buffer and concentration : 5% NFDM/TBST Low expression : SW480 (PMID : 31324782). ab314480 demonstrated significant selectivity for a-thrombin over prothrombin. This data is displayed compared to ab208589 which demonstrates enhanced selectivity for prothrombin over a-thrombin. The expression profile/molecular weight observed is consistent with what has been described in the literature (PMID : 31324782, 21527525, 22345489). Lanes 1-3 are applied with Anti-Thrombin antibody [EPR25304] (ab314480) at 1/1000 dilution and lanes 4-6 are applied with Anti-Prothrombin antibody [EPR20159] (ab208589) at 1/1000 dilution. In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

Lanes 1 - 3:

Western blot - Anti-Thrombin antibody [EPR25304-12] (<a href='/ko/products/primary-antibodies/thrombin-antibody-epr25304-12-ab314480'>ab314480</a>) at 1/1000 dilution

Lanes 4 - 6:

Western blot - Anti-Prothrombin antibody [EPR20159] (ab208589) at 1/1000 dilution

Lanes 1 and 4:

HepG2 (human hepatocellar carcinoma epithelial cell) whole cell lysate at 20 µg

Lanes 2 and 5:

Caco-2 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lanes 3 and 6:

SW480 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 38 kDa,37 kDa

false

Exposure time: 59s

관련 conjugated 항체와 다양한 조성의 항체 (1)

  • Carrier free

    Anti-Prothrombin antibody [EPR20159] - BSA and Azide free

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20159

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, ICC/IF, Flow Cyt (Intra), WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/600", "FlowCytIntra-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>" } } }

제품 세부 정보

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
보관 버퍼
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Prothrombin also known as coagulation factor II is an important protein in blood clotting with an approximate mass of 72 kDa. This protein is synthesized in the liver and is expressed mainly in the plasma as an inactive precursor of thrombin. Prothrombin plays a pivotal role in the conversion into active thrombin through factor X activation in the presence of ionized calcium and phospholipid surfaces. Thrombin then further acts to convert fibrinogen into fibrin leading to clot formation. Prothrombin also can interact with various cellular receptors influencing other pathways beyond coagulation.
Biological function summary

Prothrombin regulates hemostasis and is part of the prothrombinase complex along with factor Xa factor Va calcium ions and phospholipids. This complex allows for the precise regulation of thrombin generation on the surface of activated platelets. By controlling the formation of thrombin prothrombin affects not only blood coagulation but also influences cell proliferation inflammation and tissue repair. The careful balance of prothrombin activation is important to prevent excessive bleeding or clot formation.

Pathways

Prothrombin is an essential component of the coagulation cascade especially the intrinsic and extrinsic coagulation pathways. In these pathways it links with proteins such as fibrinogen and factor X contributing to the amplification and perpetuation of thrombin generation. Additionally thrombin produced from prothrombin engages in a feedback loop to further enhance factor V VIII and XI activation. Through these actions prothrombin helps maintain normal coagulation but must be tightly regulated to prevent thrombotic complications.

Prothrombin is implicated in conditions like prothrombin thrombophilia and liver disease. Prothrombin thrombophilia is a genetic disorder that increases the risk for venous thromboembolism due to the presence of the G20210A mutation in the prothrombin gene. Moreover impaired prothrombin synthesis can occur as a result of liver disease leading to a higher bleeding risk. In thrombotic conditions proteins like protein C and antithrombin work to combat excessive prothrombin-generated thrombin underlining the necessity for balance and regulation in hemostatic processes.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. Activates coagulation factor XI (F11); activation is promoted by the contact with negatively charged surfaces (PubMed : 2019570, PubMed : 21976677). Triggers the production of pro-inflammatory cytokines, such as MCP-1/CCL2 and IL8/CXCL8, in endothelial cells (PubMed : 30568593, PubMed : 9780208).
See full target information F2

제품이 사용된 논문 (4)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Frontiers in immunology 16:1616715 PubMed40761801

2025

Development of Z- granzyme B immunoaffitoxin: dual mechanisms targeting hpv16-positive cervical cancer through epithelial-mesenchymal transition inhibition and cell death.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaochun Tan,Jiani Yang,Yanheng Li,Kairong Wan,Sicong Feng,Xishang Jing,Zhenyun Xie,Lifang Zhang,Wenshu Li

JCI insight 8: PubMed36802340

2023

Neutrophil extracellular traps contribute to coagulopathy after traumatic brain injury.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaqi Jin,Fang Wang,Jiawei Tian,Xinyi Zhao,Jiawei Dong,Nan Wang,Zhihui Liu,Hongtao Zhao,Wenqiang Li,Ge Mang,Shaoshan Hu

Cell reports 35:108930 PubMed33826899

2021

Insight into the human pathodegradome of the V8 protease from Staphylococcus aureus.

Applications

Unspecified application

Species

Unspecified reactive species

Andrew Michael Frey,Dale Chaput,Lindsey Neil Shaw

EBioMedicine 53:102671 PubMed32114386

2020

Interactions between neutrophil extracellular traps and activated platelets enhance procoagulant activity in acute stroke patients with ICA occlusion.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Zhou,Tao Li,Jiaqi Jin,Yingmiao Liu,Baorong Li,Quanye Sun,Jiawei Tian,Hongtao Zhao,Zhihui Liu,Shuai Ma,Shuoqi Zhang,Valerie A Novakovic,Jialan Shi,Shaoshan Hu
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com